Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
pTVG-HP DNA Vaccine in Non-Metastatic Castrate-Resistant Prostate Cancer
NCT00849121Phase 2Completed
- Sponsor
- University of Wisconsin–Madison
- Start
- Mar 2009
- Primary completion
- Feb 2014
- Modality
- Prophylactic Vaccines, DNA Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of pTVG-HP plasmid DNA vaccine in prostate cancer (PCa), sponsored by University of Wisconsin–Madison. Started Mar 2009; status: completed.
02
Drugs
pTVG-HP plasmid DNA vaccine
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00849121.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00849121.